DIAPH2 gene polymorphisms and laryngeal cancer risk in men

J Cancer Res Clin Oncol. 2024 Jun 7;150(6):295. doi: 10.1007/s00432-024-05820-4.

Abstract

Background: The DIAPH2 gene is one of the genes commonly associated with laryngeal squamous cell carcinoma (LSCC). In our study, we considered the four polymorphisms of this gene, i.e. rs5920828, rs4322175, rs12851931 and rs5921830 as potential genetic risk factors for LSCC.

Methods: We determined the genotyping of the genetic variants of DIAPH2 in 230 male patients with histologically confirmed LSCC compared to the European population. Demographic and environmental exposure data of each subject were examined. To conduct the genetic tests, extraction of total DNA was performed. We genotyped all four variants in each patient and determined their frequencies.

Results: In the case of the rs12851931 polymorphism in the DIAPH2 gene, a significant difference was observed in the distribution of the T stage depending on the polymorphism. Heterozygotes were more often associated with T2 stage, while homozygotes were more likely to have higher tumor stages. The rs12851931 homozygotes of DIAPH2 were statistically significantly more prevalent in smokers. The results suggested that rs12851931 polymorphism in DIAPH2 could increase the onset risk of LSCC.

Conclusions: Our results provide further information on the role of the DIAPH2 gene in the pathogenesis of LSCC.

Keywords: DIAPH2 gene polymorphisms; Genetic factor; Laryngeal cancer risk.

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Squamous Cell / genetics
  • Carcinoma, Squamous Cell / pathology
  • Formins* / genetics
  • Genetic Predisposition to Disease*
  • Genotype
  • Humans
  • Laryngeal Neoplasms* / epidemiology
  • Laryngeal Neoplasms* / genetics
  • Laryngeal Neoplasms* / pathology
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide*
  • Risk Factors

Substances

  • Formins
  • DIAPH2 protein, human